Clinical Trial Update: Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating decitabine with umbilical cord blood for poor graft function after allogeneic hematopoietic stem cell transplantation is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poor Graft Function

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Poor Graft Function | Phase 3 | Status: NOT_YET_RECRUITING